Affluent Medical SA

EPA:AFME.PA

1.865 (EUR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023202220212020201920172016
Revenue 1.2241.3391.4510.8241.4290.0430.003
Cost of Revenue 2.4132.4432.5183.1082.265.9963.798
Gross Profit -1.189-1.104-1.067-2.284-0.831-5.953-3.795
Gross Profit Ratio -0.971-0.824-0.735-2.772-0.582-138.442-1,265
Reseach & Development Expenses 00.0520.0230.009000
General & Administrative Expenses 14.2115.1625.1893.33212.9522.4291.787
Selling & Marketing Expenses 0.0790.0810.020.0210.03800
SG&A 14.295.2435.2093.35312.992.4291.787
Other Expenses -0.0976.5785.5266.133-0.0341.9771.507
Operating Expenses 14.38711.82110.7359.48613.0244.4063.294
Operating Income -16.8-14.29-13.233-12.594-15.284-10.295-7.089
Operating Income Ratio -13.725-10.672-9.12-15.284-10.696-239.419-2,363
Total Other Income Expenses Net -0.21-1.11-2.024-1.934-1.412-0.126-0.133
Income Before Tax -17.01-15.4-15.257-14.528-16.696-10.421-7.222
Income Before Tax Ratio -13.897-11.501-10.515-17.631-11.684-242.349-2,407.333
Income Tax Expense -1.357-0.173-0.437-0.209-1.297-1.669-1.386
Net Income -15.653-15.227-14.82-14.319-16.589-8.752-5.837
Net Income Ratio -12.788-11.372-10.214-17.377-11.609-203.535-1,945.667
EPS -0.54-0.81-0.8-0.77-0.89-0.74-0.48
EPS Diluted -0.54-0.81-0.8-0.77-0.89-0.72-0.48
EBITDA -14.387-11.796-10.843-10.495-13.024-9.992-6.845
EBITDA Ratio -11.754-8.81-7.473-12.737-9.114-232.372-2,281.667